Treatments of the Necrosed Immature Teeth (REV)

Regional University Hospital Center (CHRU)

Status and phase: Terminated; Phase 2

Conditions: Clinical and Radiographic Success in 24 Months

Treatments: Device: Hydroxide of calcium; Device: MTA

Study type: Interventional

Funder types: Other

Identifiers

NCT02064517

29BRC12.0131

Revascularisation pulpaire

Details and patient eligibility

About

Estimate if the technique of revascularisation pulpaire (with some hydroxide of calcium) allows to obtain a better forecast of preservation of the tooth without complication than the conventional technique with the creation of an apicale barrier in the MTA in 24 months.

Enrollment: 16 patients

Sex: All

Ages: 6+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients presenting one or monoradicular immature definitive several teeth ( open apex) with a pulpar necrosis,
• 6-year-old patients in 17 years the parents(relatives) of which agree to give a lit(enlightened) written consent or patients of more than 18 years old.

Exclusion criteria

• general order: any pathology or treatment(processing) dissuading a treatment(processing) endodontic (patients at risk of infectious endocarditis) or pulling(entailing) an immunosuppression (diabetes, HIV, immunosuppresseurs treatments(processings) post-transplant, long-term corticoids, chemotherapies), allergy known about the used, antecedent products of cervico-facial radiotherapy, presenting subject of the communications problems, the pregnancy and the feeding.
• local order: generalized periodontal disease or superior located(localized) periodontal pocket in 3mm, crack or fracture(split) radiculaire, radiculaire reduction of the necrosed immature tooth

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

16 participants in 2 patient groups, including a placebo group

Conventional technique

Placebo Comparator group

Description:

Apical MTA barrier

Treatment:

Device: MTA

Revascularisation pulpaire

Experimental group

Description:

hydroxide of calcium

Treatment:

Device: Hydroxide of calcium